Prevalence of hepatitis B virus markers in surgeons in Lagos, Nigeria

East African Medical Journal

Volumn 77, Issue 5, 2000, Pages 283-285

  Belo, A C ^a  

^a Ashford Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; HEPATITIS B; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; NIGERIA; OCCUPATIONAL DISEASE; SURGERY;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; MALE; MIDDLE AGED; NIGERIA; OCCUPATIONAL DISEASES; SEROEPIDEMIOLOGIC STUDIES; SURGERY;

EID: 0034178106     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Marjohs, H.S., Alter, M.J. and Hadler, S.C., Hepatitis B Evolving epidemiology and implications for control. Sem. Liver Dis. 1991; 11: 84-92
2. Hudson, C.P. How AIDS forces reappraisal of hepatitis B virus control in Sub-Saharan Africa (viewpoint). Lancet 1990, 336: 1364-9
3. Beasley, R.P. and Hwang, L.Y. Epidemiology of hepatocellular carcinoma. In Vijas G N. Dienstag J L Hoofnagle J H(eds.); Viral hepatitis and liver disease. Grune and Stratton, Orlando, Florida. 1984; 209-4
4. Ayoola, E.A., Adelaja, A.B. Subdeterminants and Incidence of hepatitis B cantigen in carriers of hepatitis B surface antigen. Nig. Med. Pract. 1986; 22: 133-6
5. Yeoh, E.K. Hepatitis B virus infection in children. Vaccine 1990; 8: 524-9.
6. Gibas, A., Blewett, D.R., Schenfeld D.A., Dienstag, J.L. Prevalence and incidence of viral hepatitis in health workers in the pre-hepatitis B vaccination era. Amer. J. Lpid. 1992; 136: 603-10
7. Finch, R.G. Time for action on hepatitis B immunisation (Editorial). Brit. Med. J. 1987; 294: 197-8
8. Goldsmith, R., Zakaria, S., Zakaria, M.S., Mabrouk, M.A. Hanafy, A.M. El Kaliouby A.H., El-Rifae M. Occupational exposure to hepatitis B virus in hospital personnel in Cairo. Egypt Acta. Tropica, 1989; 46: 283-90
9. Olubuyide, I.O., Ola. S.O., Aliyu, O.O., Dosumu, J.J., Arotiba, O.A., Olaleye, G. N. et al. Hepatitis B and C in doctors and dentists in Nigeria, Quart. J. Med. 1997; 90: 417-22
10. Romieu, I., Sow. I., Lu S., Larogue, G., Prince -David. M., Romet-Lemonne, J.L., Prevalence of hepatitis B markers among hospital workers in Senegal. J. Med. Virol. 1989; 27: 282-7
11. Tsega, E., Horton, J., Nordenfelt, E., Hansson, B., Wolde-Hawariat, G., Lindberg, J. Do hospital personnel in hyperendemic areas require immunisation against hepatitis B virus infection? Is vertical transmission of hepatitis B virus infection common in this group? Ethiop. Med. J. 1989; 27: 101-6
12. Szmuness, W., Dienstag, J.L. Purcell, R.H., Steven, C.E., Wong, D.C., Ikram, H. et al. The prevalence of antibody to hepatitis B antigen in various parts of the world: a pilot study. Amer. J. Epidem. 1977; 106: 392-8.
13. Banninger, P., Altorfer, J., Frosner, G.G., Pirovino, M., Gudat, F., Bianchi, L. et al. Prevalence and significance of antiHBc IgM (radioimmunoassay) in acute and chronic hepatitis B and in blood donors, Hepatology 1993; 3: 337-42
14. Nasidi, A., Harry. T.O., Vyazov, S.O., Munube, G.M., Azzan, B.B., Ananiev, V.A. Prevalence of hepatitis B virus markers in representative areas of Nigeria. Int. J. Epidem. 1986; 15: 274-6.
15. Doebbeling, B.N., Wenzel, R.P. The direct costs of Universal precautions in a teaching hospital. J. Amer. Med. Ass. 1990; 264: 2083-7
16. Reingold, A.L., Kane, M.A., Hightower, A.V. Failure of gloves and other protective devices to prevent transmission of hepatitis B virus to oral surgeons. J. Amer. Med. Ass. 1988; 259: 2558-60.
17. Lin, D.B., Wang, H.M., Lee, Y.L., Ling, U.P., Changlai, S.P., Chen, C.J. Immune status in preschool children born after mass hepatitis B vaccination program in Taiwan. Vaccine 1998; 16: 1683-7
18. Al-Faleh, F.Z., Al-Jeffri. M., Ramia, S., Al-Rashed, R., Arif, M., Rezeig, M. et al. Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. J. Infect. 1999; 39: 167-70.